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In this study, the antimicrobial activity of leaves and branches of 
Eriobotrya japonica, a Lebanese endegenious plant, against Extended 
Spectrum Beta Lactamase -producing Escherichia coli and Klebsiella 
pneumoniae was determined  and the specific plant fraction 
responsible for this antimicrobial activity were identified. The plants 
were extracted with ethanol to yield the crude extract which was 
further subfractionated by different solvents to obtain the petroleum 
ether, the dichloromethane, the ethyl acetate and the aqueous 
fractions. The Minimum Inhibitory Concentrations (MIC) and 
Minimum Bactericidal Concentrations (MBC) were determined using 
broth microdilution. Both inhibitory and bactericidal effects of 
Eriobotrya japonica on Escherichia coli and Klebsiella pneumoniae 
were mainly observed with the crude extract of the plant, the ethyl 
acetate, the Dichloromethane, and the aqueous fractions. The 
antibacterial effect of the Petroleum ether fraction was limited with 
the leaf extract; however, it was acceptable with the branch extract. 
The lowest MIC90 was observed with ethyl acetate fraction for both 
leaf and branch extracts with Escherichia coli and Klebsiella 
pneumoniae. The concentrations at which most of strains were 
inhibited ranged between 40 μg/μl and 80 μg/μl. MICs and MBCs 
effects were detected within 1 dilution. This study constitutes a good 
example for the screening of antimicrobial activities of plants on 
highly resistant organisms of clinical importance; however, toxicity 
of these extracts needs more investigation. 
Keywords: Eriobotrya japonica, Extended Spectrum Beta 
Lacatamase, Minimum Inhibitory Concentration, medicinal herbs. 
 
Introduction 
The appearance of resistant pathogens paved the 
way to the occurrence of infections that are only 
treated by a limited number of antimicrobial 
agents. Bacterial resistance to antimicrobial 
agents is a medical problem with public health, 
socio-economic and even political implications. 
The change in the resistance patterns will 
continue to menace the developed and developing 
countries. The world is nowadays witnessing an 
emergence of several multi-drug resistant 
organisms rendering the treatment options more 
and more limited. Resistance in Gram negative 
bacteria presents a major challenge for the 
antimicrobial therapy and significantly narrows 
the treatment options of human infections [1]. 
Extended Spectrum Beta-Lactamase (ESBL) 
producing bacteria are spread worldwide. Their 
prevalence in Lebanon is increasing through the 
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years and their incidence depends on the region 
and environment [2, 3]. In view of the increase in 
ESBL resistance, and the negligible development 
of antibiotics in the past few years, there is an 
urgent need for new antibacterial compounds in 
order to fight the emergence of these new 
resistant pathogens.  
 
Plants have been used as remedies and treatments 
of diseases; there is evidence that they were used 
in ethnomedicine 60,000 years ago in Iraq [4,5].  
The Middle Eastern Mediterranean region is rich 
in plant species; there are about 2,600 species of 
which many are considered to have medicinal 
effects. However, there is relatively limited 
research on medicinal plants in this region [5]. 
Plant derived antimicrobials represent a vast 
untapped source for medicines and further 
exploration of plant antimicrobials needs to occur 
[5]. In consequence, plants are starting to be 
considered as the base of modern medicine and 
antibiotic production [6]. We had previously 
studied the antibacterial activity of Rosmarinus 
officinalis, Origanum majorana, and Trigonella 
foenum-graecum and found important effect on 
highly resistant bacteria [7] 
 
The antimicrobial activity of a plant is highly 
related to secondary substances that are 
synthetized and produced by these plants. 
Secondary metabolites are substances of low 
molecular weight, which were not products of the 
primary metabolic pathway of the producing 
organism and at first thought to be with no 
advantage to the plant. Nowadays it is believed 
that they have vital functions. They may act as 
messenger molecules under specific 
circumstances (e.g. against the aggression) or 
natural pressures in order to protect the producer 
organism. They also give plants their pigment 
and odors [8].  
 
Eriobotrya japonica,  
A member of the Rosaceae family, is an Asian 
plant with fruits known as loquat.  Its leaves have 
been used in folk medicine for treatment of 
chronic bronchitis, coughs, phlegm, high fever, 
and ulcers in Japan and other Asian countries. It 
contains terpenoids and flavonoids that have been 
found in the leaves and some of these compounds 
have been reported to be biologically active, 
exhibiting anti-inflammatory, anti-HIV, and 
hypoglycemic properties [9, 10]. Eriobotrya 
japonica was shown to have antibacterial activity, 
the water extract inhibited the growth some gram 
positive and gram negative bacteria [11]. The 
seeds extracts were also shown to suppress 
hyperglycemia and improve glucose tolerance in 
mice with type 2 diabetes [9]. 
 
The aim of this study was to determine the 
antimicrobial activity leaf and branch extracts of 
this plant against microorganisms with high level 
of acquired resistance to traditional antibiotics 
(Escherichia coli and Klebsiella pneumoniae 
producing Extended Spectrum Beta Lactamases) 
and to identify the specific fraction/s responsible 
for the antimicrobial activity. 
 
Materials and Methods 
Bacterial strains 
Twenty strains of Escherichia coli and ten strains 
of Klebsiella pneumoniae were isolated at the 
clinical microbiology laboratory of the Saint 
George Hospital-University Medical Center, 
between December 2007 and May 2009. In 
addition to being ESBL producers, these isolates 
exhibited different profiles of resistance. 
 
Selected Plants 
The herbal sample consisted of leaves and 
branches of an indigenous Lebanese plant: 
Eriobotrya japonica. They were collected from 
different Lebanese areas and directly from nature. 
They were identified and characterized by a 
taxonomist. The name of the plant, time, place 
and date of collection were recorded. 
 
Antimicrobial activity,  
ESBL and AmpC Detection.  
The Antimicrobial Susceptibility Testing was 
performed as recommended by the Clinical and 
Laboratory Standards Institute [12,13]. The 
production of ESBL was detected phenotypically 
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using the double disk synergy method described 
previously [14]. The strain showing a key-hole 
effect between one or more of the third 
cephalosporin disks and the 
amoxicillin/clavulanic acid disk or showing a 
boost of the inhibition zone of one of the third 
generation cephalosporin disks toward the 
amoxicillin/clavulanic acid disk was considered 
as an ESBL producer. The antimicrobial agents 
that were tested were: ampicillin, piperacillin, 
imipenem, amoxicillin/clavulanic acid, 
piperacillin/tazobactam, cephalotin, cefoxitin, 
cefuroxime, ceftriaxone, ceftazidime, cefepime, 
gentamicin, ciprofloxacin, ofloxacin, tigecycline 
and trimethoprim/sulfamethoxazole. The 
breakpoints for the different antibacterial agents 
recommended by the CLSI were used. Since 
tigecycline has no CLSI breakpoints, the SFM 
guidelines were adopted for this antibiotic as 
alternative (Diameter < 19 mm for Resistance). 
Although resistance to cephamycins cannot be a 
confirmatory test for AmpC production and 
might be conferred sometimes by ESBLs, 
resistance to cephamycin was looked at as an 
indicator for AmpC production since this is true 
in the majority of the cases. 
 
Preparation of Crude Extract. Fresh plants 
were dried in the shade at room temperature and 
ground in a coffee bean grinder. The dried plant 
material was weighed and then soaked in 80% 
ethanol for 7 days with continuous shaking in a 
shaker at room temperature. At day seven the 
plant material was filtered and the filtrate 
collected. This was repeated and the filtrates were 
combined and concentrated in a rotary evaporator 
to obtain the crude extract (fraction 1).  
 
Fractionation Method.  
The crude extract of each plant was further 
partitioned by extraction with different solvents 
in a 1:1 (v/v) ratio in order to sub-fractionate the 
plant components according to their polarity: 
petroleum ether (fraction 2), dichloromethane 
(fraction 3), and ethyl acetate (fraction 4). 
Extractions were repeated three times and 
fractions were combined. The remaining aqueous 
layer was collected as fraction number 5.  
Fractions 1 and 5 were dried using a freeze dryer, 
but fractions 2, 3 and 4 were dried under the hood 
to dryness due to the inconvenience of 
introducing vapor solvent into the freeze dryer. 
Controls were prepared for each fraction by 
drying the same amount of solvent and following 
the same subfractionation method without plant 
extract (solvent control). 
 
Study of Antimicrobial Activity of the Plant 
Extracts 
The plant powders were weighed and dissolved in 
sterile distilled water. The solutions were filtered 
through 0.22 μm sterile filter membranes and 
stored at 4 ˚C for further use. The concentration 
of the original solution of the plant 
extract/fraction corresponds to the concentration 
obtained after re-suspension of the dried plant 
extracts. This was used as the stock solution and 
the most concentrated one from which the MIC 
series were prepared. 
 
MIC and MBC Determination 
The Microdilution Broth Method was used for the 
determination of the MIC of plant extracts as 
recommended by the Clinical and Laboratory 
Standards Institute [12, 13]. Broth (100 µl) was 
dispensed in each well of a sterile microdilution 
tray. An appropriate volume of plant extract 
suspension was added to the first tube in each 
series (after removing the same volume of broth) 
in order to achieve the desired concentration after 
the addition of the bacterial inoculum. A 
standardized bacterial inoculum was prepared and 
adjusted to 0.5 McFarland and then diluted to 106 
CFU/ml. Within 15 minutes, the wells were 
inoculated with 100µl of this inoculum resulting 
in a 1:2 concentration of the content of the well in 
plant extract and of the bacterial suspension 
(5x105 CFU/ml). A routine bacterial count was 
performed in duplicates to verify the bacterial 
concentration. Positive and negative control wells 
were used. The negative control well consisted of 
200 μl of MHB, the positive well consisted of 
200 μl MHB with a bacterial suspension but 
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Ec001SGH R R R S R R S R R R R S S S S S S S ESBL+ QS 
Ec002SGH R R R S R R S R R R R S S S S S S S ESBL+ QS 
Ec003SGH R R R S R R R R R R R S R S R R R S ESBL+ QR AmpC +
Ec004SGH R R R S R R R R R R R S R S R R R S ESBL+ QR AmpC +
Ec007SGH R R R S R R S R R R R S S S R R R S ESBL+ QR 
Ec010SGH R R R S R R S R R R R S S S S R R S ESBL+ QR 
Ec011SGH R R R S R R S R R R R S R S R R R S ESBL+ QR 
Ec012SGH R R R S R R S R R R R S R S R R R S ESBL+ QR 
Ec013SGH R R R S R R S R R R R S R S R S S S ESBL+ QS 
Ec016SGH R R R R R R R R R R R S R S R R R S ESBL+ QR AmpC +
Ec017SGH R R R S R R R R R R R S R R S S S S ESBL+ QS AmpC +
Ec018SGH R R R S R R R R R R R S R S R R R S ESBL+ QR AmpC +
Ec019SGH R R R S R R S R R R R S R S R R R S ESBL+ QR 
EC020SGH R R R S R R S R R R R S S S R R R S ESBL+ QR 
EC021SGH R R R S R R S R R R R S S S R R R S ESBL+ QR 
Ec023SGH R R R S R R S R R R R S S S R R R S ESBL+ QR 
Ec026SGH R R R S R R S R R R R S R S R S S S ESBL+ QS 
Ec030SGH R R R S R R S R R R R S R S R R R S ESBL+ QR 
EC031SGH R R R S R R S R R R R S R S R R R S ESBL+ QR 
Ec032SGH R R R S R R S R R R R S S S S S S S ESBL+ QS 
Kp001SGH R R R S R R S R R R R S R S R S S S ESBL+ QS 
Kp002SGH R R R S R R S R R R R S R S R S S S ESBL+ QS 
Kp005SGH R R R S R R S R R R R S R S R S S S ESBL+ QS 
Kp006SGH R R R S R R S R R R R S R S R S S S ESBL+ QS 
Kp007SGH R R R R R R S R R R R S R S R R R I ESBL+ QR 
Kp008SGH R R R S R R S R R R R S R S R R R S ESBL+ QR 
Kp009SGH R R R R R R S R R R R S R S R R R S ESBL+ QR 
Kp010SGH R R R S R R S R R R R S S S R R R S ESBL+ QR 
Kp013SGH R R R S R R S R R R R S S S R S S S ESBL+ QS 
Kp016SGH R R R S R R S R R R R S R S S R R S ESBL+ QR 
Ec: Escherichia coli, Kp: Klebsiella pneumoniae, AM:ampicillin, AMC:amoxicillin/clavulanic acid, PIP:piperacillin, 
TZP:piperacillin/tazobactam, CF:cephalotin, CXMcefuroxime, FOX:cefoxitin, CTX:cefotaxime, CRO:ceftriaxone, 
CAZ:ceftazidime, CEF:cefepime, IMP:imipenem, GN:gentamicin, AN:amikacin, SXT:trimethoprim/sulfamethoxazol, 
OF:ofloxacin, CIP:ciprofloxacin, TGC:tigecycline  QR: quinolone Resistant, QS: quinolone sensitive S: Sensitive, I: 
Intermediate, R: Resistant; AmpC +: naturally occurring Cephalsporinase; ESBL+: ESBL producer 
 
The tray was incubated at 35 °C for 18-24 hours 
after which the MIC was recorded as the highest 
dilution of each plant extract that still retained an 
inhibitory effect resulting in no visible growth or 
in other terms absence of turbidity observed with 
the naked eye. The MBC was determined by sub-
culturing samples from the tubes with 
concentrations above the MIC on new plates of 
MHA. The MBC corresponded to the lowest 
concentration of the extract associated with no 
bacterial culture. 
All experiments were performed three 
independent times in duplicate form. The MIC90 
is defined as the Minimum Inhibitory 
Concentration required to inhibit the growth of 
90% of organisms, it was calculated as the 
percentile below which 90% of the individual 
MICs values fall. In view of the relatively small 
population of tested bacteria, it was not 
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ether (μg/μl)  
Dichloromethane 
(μg/μl)   
Ethyl acetate 
(μg/μl)  Aqueous (μg/μl) 
 MIC MBC  MIC MBC  MIC MBC  MIC MBC  MIC MBC          
Ec001SGH 80 80  80 80  X X  X X  40 40 
Ec002SGH 80 80  ND ND  ND ND  2.5 10  80 ND 
Ec003SGH 80 80  ND ND  40 40  2.5 10  80 80 
Ec004SGH 80 80  80 80  X X  X X  40 ND 
Ec007SGH 80 ND  40 80  40 40  10 10  40 ND 
Ec010SGH 80 80  80 80  40 40  2.5 10  40 40 
Ec011SGH 80 80  40 80  80 ND  5 5  40 ND 
Ec012SGH 40 40  40 80  20 80  40 40  40 80 
Ec013SGH 40 80  80 ND  20 40  80 80  40 80 
Ec016SGH 40 80  ND ND  40 40  5 5  20 80 
Ec017SGH 80 80  40 80  ND ND  5 5  ND ND 
Ec018SGH ND ND  ND ND  ND ND  10 20  80 80 
Ec019SGH 40 80  80 80  80 80  5 10  40 40 
Ec020SGH 80 ND  ND ND  ND ND  20 80  40 ND 
Ec021SGH ND ND  80 80  40 80  X X  20 40 
Ec023SGH 40 80  40 80  40 40  X X  40 80 
Ec026SGH 80 80  80 80  40 40  2.5 10  40 40 
Ec030SGH 80 80  80 ND  40 40  80 80  40 80 
Ec031SGH 80 80  80 80  40 40  5 10  40 80 
Ec032SGH 80 ND  80 80  20 ND  5 10  ND ND 
MIC90 80 >80  >80 >80  64 80  60 80  80 >80 
Kp001SGH 80 80  ND ND  5 10  2.5 5  40 ND 
Kp002SGH 80 80  ND ND  20 20  40 40  80 ND 
Kp005SGH 80 80  ND ND  ND ND  5 10  80 ND 
Kp006SGH ND ND  ND ND  ND ND  20 20  80 80 
Kp007SGH ND ND  ND ND  40 40  5 20  80 80 
Kp008SGH 80 ND  80 80  40 80  5 10  80 ND 
Kp009SGH ND ND  ND ND  40 ND  5 10  80 ND 
Kp010SGH 80 ND  80 80  80 80  80 ND  80 ND 
Kp013SGH 80 80  80 ND  80 80  80 ND  80 ND 
Kp016SGH 80 80  ND ND  40 40  10 40  80 ND 
               
MIC90 80 80  NA NA  80 80  26 40  80 NA 
MIC:Minimum Inhibitory Concentration, MBC: Minimum Bactericidal Concentration, ND: Not Detected, X: missing extract, 
μg: microgram, μl: microliter; N/A: Not Applicable. 
 
Results  
Resistance Phenotypes of the tested strains 
As shown in z1, the patterns of resistance of the 
tested strains could be devided into four 
categories: 
• AmpC negative Quinolone resistant ESBL 
producers. 
• AmpC negative Quinolone susceptible ESBL 
producers. 
• AmpC positive Quinolone resistant ESBL 
producers. 
• AmpC positive Quinolone susceptible ESBL 
producers. 
 
Inhibitory and Bactericidal Activities of 
Eriobotrya japonica 
Antimicrobial activity of leaves  
As table 2 shows, both inhibitory and bactericidal 
effects of Eriobotrya japonica (leaves) on 
Escherichia coli and Klebsiella pneumoniae were 
mainly observed with the crude extract of the 
plant, the ethyl acetate, the Dichloromethane, and 
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the Petroleum ether fraction was limited.  The 
lowest MIC90 was observed with ethyl acetate 
fraction at 26 μg/μl for Klebsiella pneumoniae. 
The lowest MIC was recorded for the ethyl 
acetate fraction with Escherichia coli and 
Klebsiella pneumoniae at 2.5 μg/μl. In addition, 
the MIC and MBC effects were detected within 1 
dilution. Eriobotrya japonica leaf crude extract, 
dichloromethane, ethyl acetate and aqueous 
fractions exhibited bactericidal effect against 
63%, 53%, 100% and 40% of the strain 
respectively. The aqueous fraction showed 
comparable antibacterial activity with 
Escherichia coli and Klebsiella pneumoniae.  
Moreover, the concentration at which most of the 
bacterial suspensions were cleared were 80 μg/μl 
for the crude extract and the aqueous fraction, 40 
μg/μl for the dichloromethane fraction and 10 
μg/μl  for the ethyl acetate fraction. Petroleum 
ether fraction exerted its bactericidal activity 
mostly at 80 μg/μl. The solvents’ controls did not 
show any antibacterial activity. Positive controls 
showed Bacterial growth while no growth was 
observed for the negative controls. 
 
Table 3: MICs and MBCs of the Different Fractions of Eriobotrya japonica branches on Escherichia coli and Klebsiella 
pneumonia. 
Bacterial 




ne (μg/μl)  
Ethyl acetate 
(μg/μl)  Aqueous (μg/μl) 
 MIC MBC  MIC MBC  MIC MBC  MIC MBC  MIC MBC          
Ec001SGH 40 ND  40 80  X X  10 10  80 80 
Ec002SGH 40 40  10 10  X X  5 10  80 80 
Ec003SGH 40 40  ND ND  X X  10 10  80 80 
Ec004SGH 40 80  ND ND  X X  2.5 2.5  40 80 
Ec007SGH 20 20  ND ND  X X  40 40  80 ND 
Ec010SGH 20 40  ND ND  X X  20 40  80 80 
Ec011SGH 40 80  80 ND  X X  2.5 5  80 80 
Ec012SGH 20 80  80 80  X X  5 5  80 80 
Ec013SGH 20 80  80 ND  X X  5 10  80 80 
Ec016SGH 20 40  ND ND  X X  2.5 2.5  40 40 
Ec017SGH 10 10  10 10  X X  10 10  40 40 
Ec018SGH 40 40  ND ND  X X  10 10  80 ND 
Ec019SGH 20 20  ND ND  X X  5 5  80 80 
Ec020SGH 80 80  ND ND  X X  10 10  80 80 
Ec021SGH 80 80  40 80  X X  2.5 2.5  20 20 
Ec023SGH 80 80  40 80  X X  2.5 2.5  40 80 
Ec026SGH 20 40  10 ND  X X  20 40  80 80 
Ec030SGH 80 80  80 80  X X  5 5  80 80 
Ec031SGH 40 40  ND ND  X X  10 20  80 80 
Ec032SGH 40 80  ND ND  X X  10 20  80 80 
               
MIC90 80 80  N/A NA  X X  20 40  80 80 
Kp001SGH 40 80  80 ND  X X  10 10  80 80 
Kp002SGH 20 20  80 ND  X X  10 10  80 80 
Kp005SGH 80 ND  10 ND  X X  10 20  80 ND 
Kp006SGH 80 80  ND ND  X X  20 20  80 ND 
Kp007SGH 40 40  ND ND  X X  10 20  80 80 
Kp008SGH 40 40  40 80  X X  5 10  80 80 
Kp009SGH 80 80  80 ND  X X  10 10  ND ND 
Kp010SGH 40 80  80 80  X X  10 20  80 80 
Kp013SGH 80 80  80 80  X X  10 10  80 80 
Kp016SGH 80 80  80 80  X X  10 10  80 80 
MIC90 80 80  80 >80  X X  11 20  80 80 
MIC:Minimum Inhibitory Concentration, MBC: Minimum Bactericidal Concentration, ND: Not Detected, X: missing extract, 
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Antimicrobial Activity of branches 
As table 3 shows, Antibacterial effects of 
Eriobotrya japonica branches on Escherichia coli 
and Klebsiella pneumoniae (Table 3) were 
observed with the crude extract of the plant, the 
ethyl acetate, the petroleum ether, and the 
aqueous fractions. The Dichloromethane 
fractionation did not reveal enough quantity to 
run all the experiments, it was therefore 
discarded. The best inhibitory activity 
represented by the lowest MIC90 was observed 
with ethyl acetate fraction at 20 μg/μl for 
Escherichia coli and at 11 μg/μl for Klebsiella 
pneumoniae. The concentrations at which most of 
strains were inhibited were 40 μg/μl for the crude 
extract, 10 μg/μl for the ethyl acetate fraction and 
80 μg/μl for the aqueous fraction. The lowest 
MIC was recorded for the ethyl acetate fraction 
with Escherichia coli at 2.5 μg/μl. The MIC and 
MBC effects were detected within 1 dilution. The 
concentrations at which most of the strains were 
killed were 40 μg/μl for the crude extract, 10 
μg/μl for the ethyl acetate fraction and 80 μg/μl 
for the aqueous and petroleum ether fractions. 
The solvents’ controls did not exert any 
antibacterial activity. Bacterial growth was 
observed for the positive controls while no 
growth was observed for the negative controls. 
 
Discussion 
Due to the high level of resistance to third 
generation cephalosporins and monobactams, the 
choice of effective and safe antibiotic treatment is 
becoming limited.  Alternative agents or extracts 
obtained from natural medicinal plants need to be 
introduced or combined with antibiotics for 
therapeutical use. In the present study, extracts 
from three different plants were tested for 
antimicrobial activity against ESBL producing 
Escherichia coli and Klebsiella pneumoniae.  
 
Most studies [7, 15-18] found more antimicrobial 
activity in plant extracts tested against Gram-
positive than Gram-negative bacteria. This was 
attributed to the fact that Gram-negative bacteria 
possess an outer membrane that acts as a barrier 
to many environmental substances [19]. 
The present study showed that different 
extracts/fractions exhibited antimicrobial activity 
against ESBL producing Escherichia coli and 
Klebsiella pneumoniae. The crude extracts, the 
ethyl acetate, the petroleum ether, the 
dichloromethane (where available) and the 
aqueous fractions of both leaf and branch extracts 
of the plant exhibited an inhibitory effect.  
 
In most of the cases, inhibitory and bactericidal 
effects were detected by the same concentrations. 
The lowest MIC was recorded with ethyl acetate 
fraction of leaf extracts at 2.5 μg/μl. 
 
In a previous study [7], we have shown that 
different extracts of Rosmarinus officinalis, 
Origanum majorana, and Trigonella foenum-
graecum inhibited the growth of ESBL producing 
Escherichia coli and Klebsiella pneumoniae at 
different rates. In that study, the MICs ranged 
between 1.25 and 80 μg/μl. The majority of these 
microorganisms were inhibited by 80 and 40 
μg/μl of the crude extracts and the petroleum 
ether fraction of Origanum majorana significantly 
inhibited 94% of the tested strains. 
 
In the present study the individual MICs varied 
between 2.5 and 80 μg/μl. Some MICs of the 
same extracts varied against the different tested 
strains, although, some of the tested strains had 
the same antimicrobial susceptibility patterns. In 
their investigation, Ahmad and Aqil [21] 
postulated that the presence of different intrinsic 
levels of tolerance to antimicrobials in the tested 
microorganisms caused the variation of the MIC 
values among the isolates with relatively similar 
antimicrobial susceptibility patterns. 
 
This study has shown that the highest 
antibacterial activity against ESBL producing 
Escherichia coli and Klebsiella pneumoniae was 
mainly manifested by ethyl acetate fractions of 
both leaf and branch extracts; the other fractions 
exhibited less antibacterial affect. However, the 
toxic effects of plant extracts were not explored 
or tested in this work. The selective toxicity of an 
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and would impact on the usefulness of this 
extract as a medicinal compound. Antibacterial 
extracts that are toxic on human cells may be 
useful as non-medicinal antimicrobial agents, 
such as surface disinfectants. In addition, 
purification and identification of the bioactive 
components is needed to examine the 
mechanisms of action of these agents especially 
that these mechanisms probably differ from those 
of the commonly used antibiotics.  
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